BOLEZN' PEDZhETA

1. Cooper C., Schafheutle K., Dennison E., et al. The epidemiology of Paget's disease in Britain. // J Bone Miner Res. 1999, v.14: 192-197

2. Hocking L.J., Herbert C.A., Nicholls R.K. et al. Genomewide search in familial Paget's disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13 and 5q35. // Am J Hum Genet, 2001; v.69:1055-1061

3. Kanis J.A. Pathophysiology and Treatment of Paget's Disease of Bone.2nd ed. 1998. Martin Dunitz, London, UK

4. Maricic M. The use of Zoledronic acid for Paget's disease of bone. // Current osteoporosis reports 2006, v.4: 40-44

5. Meunier P.I., Vignot E. Therapeutic strategy in Paget's disease of bone. // Bone. 1995; v.17: 489S-491S

6. Reid I.R., Miller P., Lyles K. еt al. Comparison a single infusion of zoledronic acid with risedronate for Paget's disease // The New Engl. J. Med. 2005; v.353:898-908

7. Selby P.L., Davie M.W.J., Ralston S.H. et al. Guidelines on the management of Paget's disease of bone. // Bone.2002; v.31: 366-373

8. Siris E.S., Roodman G.D. Paget's disease of bone. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Sixth Edition. 2006 by ASBMR. Founding editor M. J. Favus. p.320-330